Annual SGA
$7.08 M
-$4.39 M-38.26%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual SGA is $7.08 million, with the most recent change of -$4.39 million (-38.26%) on December 31, 2023.
- During the last 3 years, AMPE annual SGA has risen by +$429.00 thousand (+6.45%).
- AMPE annual SGA is now -38.26% below its all-time high of $11.47 million, reached on December 31, 2022.
Performance
AMPE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$973.00 K
-$98.00 K-9.15%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly SGA is $973.00 thousand, with the most recent change of -$98.00 thousand (-9.15%) on December 31, 2023.
- Over the past year, AMPE quarterly SGA has dropped by -$989.00 thousand (-50.41%).
- AMPE quarterly SGA is now -78.33% below its all-time high of $4.49 million, reached on December 31, 2021.
Performance
AMPE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$960.12 M
-$8.59 M-0.90%
December 31, 2023
Summary
- As of February 8, 2025, AMPE TTM SGA is -$960.12 million, with the most recent change of -$8.59 million (-0.90%) on December 31, 2023.
- Over the past year, AMPE TTM SGA has dropped by -$971.58 million (-8478.72%).
- AMPE TTM SGA is now -11164051.16% below its all-time high of -$8600.00.
Performance
AMPE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMPE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.3% | -50.4% | -8478.7% |
| 3 y3 years | +6.5% | -44.8% | -10000.0% |
| 5 y5 years | +66.1% | +1.4% | -10000.0% |
AMPE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.3% | at low | -78.3% | at low | -14.2% | at low |
| 5 y | 5-year | -38.3% | +20.0% | -78.3% | at low | -33.1% | at low |
| alltime | all time | -38.3% | >+9999.0% | -78.3% | +419.0% | <-9999.0% | at low |
Ampio Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $7.08 M(-38.3%) | $973.00 K(-9.2%) | $7.08 M(-12.3%) |
| Sep 2023 | - | $1.07 M(-11.9%) | $8.07 M(-19.1%) |
| Jun 2023 | - | $1.22 M(-68.2%) | $9.97 M(-16.9%) |
| Mar 2023 | - | $3.82 M(+94.6%) | $12.00 M(+4.7%) |
| Dec 2022 | $11.47 M(+32.2%) | $1.96 M(-34.1%) | $11.46 M(-18.1%) |
| Sep 2022 | - | $2.98 M(-8.3%) | $13.99 M(+14.0%) |
| Jun 2022 | - | $3.25 M(-1.0%) | $12.27 M(+17.7%) |
| Mar 2022 | - | $3.28 M(-27.0%) | $10.43 M(+20.3%) |
| Dec 2021 | $8.67 M(+30.4%) | $4.49 M(+257.3%) | $8.67 M(+46.0%) |
| Sep 2021 | - | $1.26 M(-10.2%) | $5.94 M(-6.1%) |
| Jun 2021 | - | $1.40 M(-7.8%) | $6.32 M(-1.2%) |
| Mar 2021 | - | $1.52 M(-13.8%) | $6.40 M(-3.7%) |
| Dec 2020 | $6.65 M(+12.8%) | $1.76 M(+7.2%) | $6.65 M(+1.7%) |
| Sep 2020 | - | $1.64 M(+11.2%) | $6.54 M(-1.4%) |
| Jun 2020 | - | $1.48 M(-16.2%) | $6.63 M(+0.9%) |
| Mar 2020 | - | $1.76 M(+7.0%) | $6.57 M(+11.4%) |
| Dec 2019 | $5.90 M(+38.4%) | $1.65 M(-5.1%) | $5.90 M(+13.2%) |
| Sep 2019 | - | $1.74 M(+22.1%) | $5.21 M(+23.2%) |
| Jun 2019 | - | $1.42 M(+30.6%) | $4.23 M(+10.6%) |
| Mar 2019 | - | $1.09 M(+13.6%) | $3.82 M(-10.3%) |
| Dec 2018 | $4.26 M(-18.9%) | $959.70 K(+26.9%) | $4.26 M(-8.9%) |
| Sep 2018 | - | $756.10 K(-25.6%) | $4.68 M(-7.1%) |
| Jun 2018 | - | $1.02 M(-33.5%) | $5.04 M(-6.0%) |
| Mar 2018 | - | $1.53 M(+11.2%) | $5.36 M(+3.2%) |
| Dec 2017 | $5.25 M(-19.6%) | $1.38 M(+23.6%) | $5.19 M(+1.3%) |
| Sep 2017 | - | $1.11 M(-17.0%) | $5.12 M(-8.0%) |
| Jun 2017 | - | $1.34 M(-1.6%) | $5.57 M(-3.8%) |
| Mar 2017 | - | $1.36 M(+4.3%) | $5.79 M(-11.4%) |
| Dec 2016 | $6.54 M(-27.8%) | $1.31 M(-16.0%) | $6.54 M(-19.3%) |
| Sep 2016 | - | $1.56 M(-0.4%) | $8.10 M(-1.1%) |
| Jun 2016 | - | $1.56 M(-26.0%) | $8.19 M(-11.9%) |
| Mar 2016 | - | $2.11 M(-26.4%) | $9.29 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $9.06 M(+1.1%) | $2.87 M(+74.3%) | $9.06 M(+54.0%) |
| Sep 2015 | - | $1.65 M(-38.2%) | $5.88 M(-21.9%) |
| Jun 2015 | - | $2.67 M(+42.3%) | $7.53 M(-8.1%) |
| Mar 2015 | - | $1.87 M(-714.1%) | $8.20 M(-8.8%) |
| Dec 2014 | $8.96 M(+19.8%) | -$305.00 K(-109.2%) | $8.98 M(-23.4%) |
| Sep 2014 | - | $3.30 M(-0.9%) | $11.72 M(+17.7%) |
| Jun 2014 | - | $3.33 M(+25.2%) | $9.96 M(+19.1%) |
| Mar 2014 | - | $2.66 M(+9.2%) | $8.36 M(+19.2%) |
| Dec 2013 | $7.48 M(+28.3%) | $2.44 M(+58.5%) | $7.01 M(-6.0%) |
| Sep 2013 | - | $1.54 M(-11.3%) | $7.46 M(+13.0%) |
| Jun 2013 | - | $1.73 M(+32.0%) | $6.61 M(+17.9%) |
| Mar 2013 | - | $1.31 M(-54.5%) | $5.60 M(-3.8%) |
| Dec 2012 | $5.83 M(+29.4%) | $2.88 M(+325.5%) | $5.83 M(+49.3%) |
| Sep 2012 | - | $678.00 K(-6.7%) | $3.90 M(-15.1%) |
| Jun 2012 | - | $727.00 K(-52.7%) | $4.60 M(+3.6%) |
| Mar 2012 | - | $1.54 M(+60.0%) | $4.44 M(-1.5%) |
| Dec 2011 | $4.50 M(-4.8%) | $960.20 K(-30.0%) | $4.50 M(-2.9%) |
| Sep 2011 | - | $1.37 M(+141.8%) | $4.64 M(-8.3%) |
| Jun 2011 | - | $567.40 K(-64.6%) | $5.06 M(-2.7%) |
| Mar 2011 | - | $1.60 M(+46.8%) | $5.20 M(+9.8%) |
| Dec 2010 | $4.73 M(+972.8%) | $1.09 M(-39.0%) | $4.73 M(+25.7%) |
| Sep 2010 | - | $1.79 M(+154.2%) | $3.76 M(+76.0%) |
| Jun 2010 | - | $705.30 K(-38.2%) | $2.14 M(+35.2%) |
| Mar 2010 | - | $1.14 M(+813.7%) | $1.58 M(+258.7%) |
| Dec 2009 | $441.10 K(+1410.6%) | $124.90 K(-25.3%) | $441.10 K(+37.7%) |
| Sep 2009 | - | $167.30 K(+12.4%) | $320.40 K(+100.9%) |
| Jun 2009 | - | $148.90 K(+3445.2%) | $159.50 K(+444.4%) |
| Dec 2008 | $29.20 K(-2.7%) | $4200.00(-34.4%) | $29.30 K(+16.7%) |
| Sep 2008 | - | $6400.00(+137.0%) | $25.10 K(+34.2%) |
| Jun 2008 | - | $2700.00(-83.1%) | $18.70 K(+16.9%) |
| Mar 2008 | - | $16.00 K | $16.00 K |
| Dec 2007 | $30.00 K | - | - |
FAQ
- What is Ampio Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual SGA year-on-year change?
- What is Ampio Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly SGA year-on-year change?
- What is Ampio Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM SGA year-on-year change?
What is Ampio Pharmaceuticals annual SGA?
The current annual SGA of AMPE is $7.08 M
What is the all time high annual SGA for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual SGA is $11.47 M
What is Ampio Pharmaceuticals annual SGA year-on-year change?
Over the past year, AMPE annual SGA has changed by -$4.39 M (-38.26%)
What is Ampio Pharmaceuticals quarterly SGA?
The current quarterly SGA of AMPE is $973.00 K
What is the all time high quarterly SGA for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly SGA is $4.49 M
What is Ampio Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AMPE quarterly SGA has changed by -$989.00 K (-50.41%)
What is Ampio Pharmaceuticals TTM SGA?
The current TTM SGA of AMPE is -$960.12 M
What is the all time high TTM SGA for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM SGA is -$8600.00
What is Ampio Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AMPE TTM SGA has changed by -$971.58 M (-8478.72%)